Skip to content

Neogen NEOG Current ratio

Current ratio at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
1.5×-0.2×
Idexx Laboratories logo
Idexx LaboratoriesIDXX
1.1×0.0×
Zoetis logo
ZoetisZTS
3.2×+1.4×
Revvity logo
RevvityRVTY
1.7×-1.9×
TEC
Bio-TechneTECH
4.5×+0.8×
Agilent Technologies logo
Agilent TechnologiesA
2.1×0.0×

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

Based on the most recent quarter.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's current ratio?
Neogen (NEOG) reported current ratio of 3.9× in Q4 2025.
How has Neogen's current ratio changed year-over-year?
Neogen's current ratio increased by 0.3% year-over-year, from 3.9× to 3.9×.
What is the long-term trend for Neogen's current ratio?
Over 4 years (2021 to 2025), Neogen's current ratio has grown at a -26.0% compound annual growth rate (CAGR), from 11× to 3.3×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.